Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating Imaging Techniques for Heart Disease in Patients with Chronic Coronary Syndrome

Official title: Multimodality Imaging and Functional Lesion Assessment in Intermediate Grade Coronary Stenosis in Chronic Coronary Syndrome: MultiInter-CCS Study

Run by Medical University of Warsaw · NCT06261866 · Data updated 2026-11-12

This study is testing how well two imaging techniques, FFR and OCT, can help people with chronic coronary syndrome and narrowed arteries understand their heart health better.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorMedical University of Warsaw
Academic / other
Locations1 site (Warsaw)
StatusRecruiting
StartedApril 7, 2011
Main results expectedDecember 31, 2024
Study endsDecember 31, 2028
Registry record updatedFebruary 15, 2024
Trial IDNCT06261866 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with chronic coronary syndrome and intermediate grade coronary stenosis.

Probably not a fit

Patients with acute coronary syndrome or significant comorbidities such as severe heart failure or acute renal insufficiency may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the diagnostic accuracy of various imaging techniques, specifically fractional flow reserve (FFR) and optical coherence tomography (OCT), in patients with chronic coronary syndrome who have intermediate coronary stenosis. It will analyze the correlation between functional indices and morphometric parameters, such as plaque type and minimal lumen area. The study will also explore how factors like age, sex, diabetes, and renal function affect these correlations. Participants will undergo both FFR and OCT examinations to provide comprehensive data on their coronary health.

Why it matters

Potential benefit: If successful, this study could enhance the diagnostic approach for patients with chronic coronary syndrome, leading to better treatment decisions.

How similar studies have gone: Previous studies have shown promising results using similar imaging techniques for assessing coronary stenosis, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years or older
* Chronic coronary syndrome defined as presence of chest pain ranked 2-3 in the Canadian Cardiovascular Society classification or positive ischemia test (exercise test, single photon emission tomography (SPECT)
* Intermediate grade coronary stenosis of 40-80% assessed visually in coronary angiography
* FFR and OCT examination of the same lesion
* The patient is willing to participate in the study and has provided a written informed consent

Exclusion Criteria:

* Acute coronary syndrome
* Proximal left main lesion
* Ostial right coronary artery lesion
* Bypass of the assessed vessel
* Contraindications for adenosine administration
* Hemodynamic instability
* Heart insufficiency in New York Heart Association (NYHA) class IV scale
* Acute renal insufficiency
* Pregnancy

Where it's running

  • Medical University of Warsaw
    Warsaw, Poland
    Recruiting

Study contacts

  • Principal investigator: Mariusz Tomaniak, MD, PhD, Assoc. Prof. — Medical University of Warsaw
  • Study coordinator: Mariusz Tomaniak
  • Email: mariusz.tomaniak@wum.edu.pl

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.